News related to Zetia (Ezetimibe) and/or conditions it is approved for
$41.5 Million Settlement Okayed in Ezetimibe Suit
Source: MedPage Today Cardiovascular [2009.10.23]
Under an agreement approved by a federal court today, the makers of ezetimibe, which is marketed as monotherapy under the trade name Zetia and as Vytorin in a combination pill, will pay $41.5 million to settle a class-action suit brought by consumers and insurers.
Ezetimibe Makes Atorvastatin More Efficient In Lowering Lipids In Men And Women Age 65 And Older
Source: Cholesterol News From Medical News Today [2009.10.29]
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
ezetimibe and simvastatin, Vytorin
Source: MedicineNet ezetimibe Specialty [2008.04.16]
Title: ezetimibe and simvastatin, Vytorin
Category: Medications
Created: 1/31/2005 10:17:00 PM
Last Editorial Review: 4/16/2008
|
